The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2016
Filed:
Mar. 04, 2011
Jun-ki Min, Gyeonggi-do, KR;
Mi-la Cho, Seoul, KR;
Yun-ju Woo, Seoul, KR;
Hye-jwa OH, Seoul, KR;
Young-ok Jung, Seoul, KR;
Geun-hyeog Lee, Gyeonggi-do, KR;
Byong-sun Choi, Seoul, KR;
Jin-ha Park, Gyeonggi-do, KR;
Eun-young Kwak, Seoul, KR;
Jun-Ki Min, Gyeonggi-do, KR;
Mi-La Cho, Seoul, KR;
Yun-Ju Woo, Seoul, KR;
Hye-Jwa Oh, Seoul, KR;
Young-Ok Jung, Seoul, KR;
Geun-Hyeog Lee, Gyeonggi-do, KR;
Byong-Sun Choi, Seoul, KR;
Jin-Ha Park, Gyeonggi-do, KR;
Eun-Young Kwak, Seoul, KR;
HANLIM PHARMACEUTICAL CO., LTD, Gyeonggi-Do, KR;
CATHOLIC UNIVERSITY ACADEMIC COOPERATION FOUNDATION, Seoul, KR;
Abstract
The present invention provides a method for preventing or treating osteoarthritis comprising administrating rebamipide or a pharmaceutical composition comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier to a subject in need thereof. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.